Northern Jiangsu People's Hospital
89
41
45
26
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 89 trials
100.0%
+13.5% vs industry average
11%
10 trials in Phase 3/4
4%
1 of 26 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (89)
Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism
Role: lead
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
Role: lead
Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection
Role: lead
Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
Role: lead
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
Role: lead
Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial
Role: lead
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
Role: collaborator
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
Role: collaborator
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
Role: collaborator
Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
Role: lead
Effect of Different Inspired Oxygen Concentrations on Intraoperative Recruitment Outcomes in Patients Undergoing Abdominal Surgery
Role: lead
Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
Role: lead
Methylene Blue for the Treatment of Septic Shock
Role: lead
The Efficacy of Personalized Local Anesthetic Dosing Based on Ultrasound-Measured Nerve Cross-Sectional Area in Brachial Plexus Block: a Non-Inferiority Randomized Controlled Trial.
Role: lead
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
Role: lead
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
Role: lead
Tislelizumab Combined With Thoracic Radiotherapy as Neoadjuvant Therapy for Resectable NSCLC
Role: lead
CAV Regimen for R/R Ph- B-ALL
Role: collaborator
CAV Regimen for R/R AML
Role: collaborator
Venetoclax Combined With Azactidine in the Treatment of ALAL
Role: collaborator